Find the latest oncology news for your sub-specialty area
ASCENT-04/KEYNOTE-D19: Sacituzumab govitecan plus pembrolizumab in metastatic triple-negative breast cancer
Metastatic triple-negative breast cancer (TNBC) remains one of the most difficult breast cancer subtypes to…